TIPS-12 PHASE I CLINICAL STUDY OF TG02 CAPSULE IN THE TREATMENT OF RECURRENT HIGH-GRADE GLIOMAS WITH FAILED TMZ TREATMENT

BACKGROUND: This study(NCT 03904628) is a dose-escalation, open-label phase I study which enrolled high grade glioma patients who failed with temozolomide(TMZ) treatment. The study purpose is to investigate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of an mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Chengcheng, Yang, Qunying, Cao, Xi, Liao, Yixiang, Li, Xiaoyi, Dai, Xiangrong, Chen, Zhongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Trials in Progress
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402332/
http://dx.doi.org/10.1093/noajnl/vdad070.143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402332/
http://dx.doi.org/10.1093/noajnl/vdad070.143

Ejemplares similares